An Initiative to Improve the Quality of Care of Infants With Neonatal Abstinence Syndrome
Top Cited Papers
- 1 June 2017
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 139 (6) , e20163360
Abstract
BACKGROUND AND OBJECTIVES: The incidence of neonatal abstinence syndrome (NAS), a constellation of neurologic, gastrointestinal, and musculoskeletal disturbances associated with opioid withdrawal, has increased dramatically and is associated with long hospital stays. At our institution, the average length of stay (ALOS) for infants exposed to methadone in utero was 22.4 days before the start of our project. We aimed to reduce ALOS for infants with NAS by 50%. METHODS: In 2010, a multidisciplinary team began several plan-do-study-act cycles at Yale New Haven Children’s Hospital. Key interventions included standardization of nonpharmacologic care coupled with an empowering message to parents, development of a novel approach to assessment, administration of morphine on an as-needed basis, and transfer of infants directly to the inpatient unit, bypassing the NICU. The outcome measures included ALOS, morphine use, and hospital costs using statistical process control charts. RESULTS: There were 287 infants in our project, including 55 from the baseline period (January 2008 to February 2010) and 44 from the postimplementation period (May 2015 to June 2016). ALOS decreased from 22.4 to 5.9 days. Proportions of methadone-exposed infants treated with morphine decreased from 98% to 14%; costs decreased from $44 824 to $10 289. No infants were readmitted for treatment of NAS and no adverse events were reported. CONCLUSIONS: Interventions focused on nonpharmacologic therapies and a simplified approach to assessment for infants exposed to methadone in utero led to both substantial and sustained decreases in ALOS, the proportion of infants treated with morphine, and hospital costs with no adverse events.Keywords
This publication has 14 references indexed in Scilit:
- A Quality Improvement Project to Reduce Length of Stay for Neonatal Abstinence SyndromePediatrics, 2015
- Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012Journal of Perinatology, 2015
- Methadone versus morphine for treatment of neonatal abstinence syndrome: A prospective randomized clinical trialJournal of Perinatology, 2014
- A Multicenter Cohort Study of Treatments and Hospital Outcomes in Neonatal Abstinence SyndromePediatrics, 2014
- Neonatal Abstinence SyndromePediatrics, 2014
- Neonatal Abstinence Syndrome Management From Prenatal Counseling to Postdischarge Follow-up Care: Results of a National SurveyHospital Pediatrics, 2013
- Neonatal Drug WithdrawalPediatrics, 2012
- Neonatal Abstinence Syndrome after Methadone or Buprenorphine ExposureNew England Journal of Medicine, 2010
- Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndromeJournal of Perinatology, 2010
- A RETROSPECTIVE STUDY OF LENGTH OF HOSPITAL STAY IN INFANTS TREATED FOR NEONATAL ABSTINENCE SYNDROME WITH METHADONE VERSUS ORAL MORPHINE PREPARATIONSAdvances in Neonatal Care, 2005